LI vs STRO
Li Auto Inc (LI) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
LI currently screens at market cap $26.62B and trailing P/E 24.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the LI and STRO stock pages for the full models.
Not investment advice.